Filter Integrity Test Market Research Report, Analysis and Forecast

Rising Pharmaceutical Applications Fueling Filter Integrity Test Market 

The filter integrity test market has been undergoing rapid transformation, largely driven by the expanding pharmaceutical sector. For instance, the global pharmaceutical manufacturing market exceeded USD 450 billion in 2023 and continues to expand at a CAGR of 7.2%, according to Datavagyanik. This consistent growth has elevated the demand for sterilizing-grade filtration solutions to ensure safety and regulatory compliance in biopharmaceutical production. Consequently, the filter integrity test market is witnessing significant traction as these tests serve as a critical quality assurance step to validate filter performance before and after batch processing. With the rise in vaccine manufacturing, monoclonal antibodies, and recombinant proteins, the filter integrity test market is positioned for robust expansion as companies strive to protect product sterility and maintain production yields. 

Biologics Revolution Expanding Filter Integrity Test Market 

Biologics production has reshaped pharmaceutical pipelines, leading to greater demand for high-performance filtration systems. For instance, Datavagyanik estimates that biologics accounted for nearly 35% of all new drug approvals in 2024, with expectations of reaching USD 450 billion in market value by 2027. Bioprocessing operations involving cell cultures, fermentation, and downstream purification depend on highly reliable sterilizing filters, creating a surge in adoption of filter integrity testing technologies. As a result, the filter integrity test market has grown steadily to support the validation of hydrophobic and hydrophilic filters used across large- and small-scale biologic manufacturing facilities. The demand is further supported by regulatory frameworks requiring proven filter integrity as a safeguard against microbial contamination. 

Regulatory Stringency Strengthening Filter Integrity Test Market 

The filter integrity test market is benefiting from increasingly stringent global regulatory standards. For instance, sterile drug manufacturing processes are governed by Good Manufacturing Practices (GMP) that mandate rigorous filter validation, including integrity testing before and after filtration runs. Regulatory bodies emphasize that any filter failure can compromise entire production batches, raising operational costs and risks to patients. Such strict protocols have strengthened the filter integrity test market, driving investments in advanced automatic integrity testing systems. Datavagyanik analysis suggests that these trends will support a steady CAGR of 8.5% for the filter integrity test market between 2024 and 2030 as regulators tighten oversight of sterile processing. 

Single-Use Technologies Bolstering Filter Integrity Test Market 

Single-use filtration systems have accelerated across the bioprocessing sector, with adoption levels growing at over 20% annually. Single-use filters simplify workflows, reduce cleaning validation burdens, and mitigate cross-contamination risks, which is especially critical in multi-product facilities. However, the shift toward disposable filtration also raises the importance of robust filter integrity verification methods. For instance, the use of integrity-tested capsule filters has surged for small-batch production in cell therapy and gene therapy processes. The filter integrity test market is thus gaining from the need to verify integrity of single-use systems prior to deployment, ensuring consistent performance across diverse product pipelines. 

Increasing Demand for Parenteral Drugs Driving Filter Integrity Test Market 

Parenteral drug manufacturing remains a key segment sustaining the growth trajectory of the filter integrity test market. Datavagyanik data indicates that global parenteral drug sales surpassed USD 100 billion in 2023, supported by rising demand for injectable vaccines, oncology therapeutics, and biosimilars. Since these formulations bypass the gastrointestinal tract and enter directly into systemic circulation, sterility is critical, heightening reliance on sterilizing-grade filtration and mandatory filter integrity verification. Filter integrity testing provides vital assurance that sterilizing-grade filters perform without leaks or defects, preserving patient safety. This reliance continues to reinforce the filter integrity test market outlook. 

Growing Biopharmaceutical Investments Elevating Filter Integrity Test Market 

Biopharmaceutical investments have been on an upward trend, with global biologics manufacturing capacity forecast to expand 1.5 times by 2028, as stated by Datavagyanik. Investment priorities include construction of new GMP-grade facilities, technology upgrades, and robust quality control systems. Filter integrity testing solutions are becoming a standard inclusion in facility upgrades to meet quality and compliance requirements. This expansion supports the filter integrity test market as manufacturers prioritize risk mitigation and process validation in critical sterile manufacturing operations. For example, new cell therapy facilities often incorporate integrity testing as an automated, validated part of their filtration skid to maintain regulatory confidence. 

Advanced Testing Automation Enhancing Filter Integrity Test Market 

Automation is reshaping the filter integrity test market by reducing human error and improving process efficiency. Modern integrity test systems now offer fully automated test sequences, data recording, and compliance-ready reporting, streamlining the verification process for manufacturers. For instance, automated bubble point testers or diffusive flow testers can complete validation within minutes, significantly cutting labor costs and increasing throughput. This technological shift has elevated the filter integrity test market by encouraging adoption across both large-scale and smaller bioprocessing lines, with Datavagyanik projecting an estimated 12% annual rise in demand for automated filter integrity testing solutions through 2030. 

Filter Integrity Test Market Benefiting from Expanding Cell Therapy Pipelines 

Cell therapy manufacturing is driving a new wave of specialized filtration needs. These processes are extremely sensitive to contamination and often involve small production batches, requiring rigorous filter integrity verification before product release. Datavagyanik projects global cell therapy spending to cross USD 25 billion by 2026, with hundreds of clinical trials underway worldwide. In these applications, the filter integrity test market gains relevance as sterility breaches can cause loss of valuable patient-specific doses, making validated integrity testing indispensable for production success. 

Increasing Bioprocessing Capacity Catalyzing Filter Integrity Test Market 

As biomanufacturers expand capacity to meet demand for vaccines, antibodies, and other therapeutic proteins, filter systems must scale in parallel. Global capacity for vaccine manufacturing alone is expected to rise 30% by 2027, says Datavagyanik, driven by pandemic preparedness strategies and emerging infectious disease countermeasures. High-volume filtration skids rely on rapid, reliable integrity testing to certify filter functionality before each campaign. Consequently, the filter integrity test market is supported by investments in capacity expansion projects that place filter validation among their highest priorities. 

Filter Integrity Test Market Size Witnessing Positive Outlook 

The filter integrity test market size reached an estimated USD 220 million in 2023 and is projected to grow steadily over the next decade. Demand is fueled by an expanding footprint of sterile drug manufacturing, growing global biologics pipelines, and the incorporation of stricter GMP-driven testing protocols. For instance, Datavagyanik anticipates that global sterile injectable manufacturing will grow at nearly 9% annually, feeding demand for high-accuracy filter validation instruments and services. In addition, the shift toward personalized medicine and complex biologic formulations is extending applications for filter integrity test market offerings, helping the sector maintain a resilient growth outlook. 

Competitive Dynamics Shaping Filter Integrity Test Market 

Competition in the filter integrity test market is characterized by technological differentiation, service support, and compliance readiness. For example, suppliers of automated integrity testing systems are focusing on reducing test cycle times, while also offering integrated digital documentation to meet 21 CFR Part 11 requirements. These competitive features strengthen value propositions in a market where customers prioritize equipment that aligns with strict audit trails and qualification processes. Datavagyanik observes that as market participants invest in R&D, the filter integrity test market will see a surge in advanced software-driven solutions for traceability and data integrity. 

Filter Integrity Test Market Advancing Through Process Intensification 

Process intensification approaches, such as continuous bioprocessing, are redefining sterile filtration strategies. In these settings, filters are exposed to higher throughputs and longer production cycles, raising the stakes for consistent integrity. Filter integrity testing becomes crucial to maintain validated performance under intensified operating conditions. Datavagyanik forecasts that adoption of continuous manufacturing in biopharma could grow by 15% annually through 2030, placing filter integrity verification systems in high demand. Therefore, the filter integrity test market is adapting with solutions that can handle more frequent and robust testing cycles, ensuring critical filters remain fully qualified. 

Filter Integrity Test Market Supported by Emerging Regulatory Frameworks 

Emerging markets are establishing stricter quality frameworks, which is positively influencing the filter integrity test market. Countries across Asia-Pacific and Latin America are modernizing their pharmaceutical GMP guidelines, making filter validation mandatory in sterile processing facilities. For example, recent quality inspection reforms in China and Brazil have created demand for local manufacturers to adopt filter integrity verification. Datavagyanik expects such regional regulatory reforms to further strengthen the filter integrity test market, promoting advanced solutions capable of withstanding evolving international standards. 

Future Outlook for Filter Integrity Test Market 

The filter integrity test market is positioned for sustained growth, driven by a combination of biopharmaceutical innovation, growing sterile manufacturing volumes, and the global rise in regulatory oversight. The introduction of next-generation therapies, from mRNA vaccines to cell and gene therapies, has expanded the role of filtration as a frontline defense for patient safety. Datavagyanik projects that these converging trends will encourage even broader adoption of automated, validated, and compliance-ready integrity testing solutions. As manufacturers prioritize product safety and efficiency, the filter integrity test market will continue to expand its reach and evolve with industry demands. 

 

North America Leading Regional Filter Integrity Test Market 

The Filter Integrity Test Market in North America has shown robust expansion, supported by the region’s concentration of biopharmaceutical production. For example, Datavagyanik notes that the United States alone accounts for nearly 40% of global biologics manufacturing capacity, creating a significant pull for advanced filter validation solutions. Increasing approvals of monoclonal antibodies, mRNA-based vaccines, and cell therapies have placed tremendous emphasis on sterility, driving consistent Filter Integrity Test demand in commercial-scale facilities as well as clinical production lines. In addition, North American GMP compliance requirements mandate thorough integrity testing for each filtration campaign, further elevating the Filter Integrity Test Market across large-scale pharmaceutical hubs in states such as California, Massachusetts, and North Carolina. 

Europe Advancing Filter Integrity Test Market with Biotech Growth 

Europe’s Filter Integrity Test Market is also strengthening thanks to investments in advanced biologics and vaccine production. Datavagyanik indicates that European biopharma manufacturing is expected to grow at nearly 8% annually through 2030, supported by strong government incentives for biosimilar development and pandemic preparedness measures. Countries such as Germany, Switzerland, and Ireland have become strategic nodes for vaccine and therapeutic protein manufacturing, where Filter Integrity Test demand is growing to protect product sterility. For instance, large contract manufacturing organizations in Europe are increasingly deploying automated integrity testing to speed up turnaround times while adhering to evolving EMA requirements. This has further supported the Filter Integrity Test Market in Europe as players adopt robust, audit-friendly testing solutions. 

Asia-Pacific Emerging as a High-Growth Filter Integrity Test Market 

The Asia-Pacific Filter Integrity Test Market is experiencing dynamic expansion, driven by a strong rise in biopharmaceutical infrastructure and local production capacity. For example, Datavagyanik expects biologics manufacturing investments across China, India, and South Korea to grow at more than 12% annually through 2028, opening fresh opportunities for filtration system suppliers. With many Asian firms entering contract development and manufacturing partnerships, Filter Integrity Test demand has intensified for new facilities producing biosimilars, vaccines, and advanced therapies. Regulatory authorities in Asia-Pacific are also adopting harmonized GMP frameworks, accelerating adoption of filter integrity testing as a fundamental quality control measure. As a result, the Filter Integrity Test Market in Asia-Pacific is forecast to deliver the highest CAGR globally over the next five years. 

Latin America Strengthening Filter Integrity Test Market 

Latin America’s Filter Integrity Test Market is gaining momentum on the back of modernization programs in local pharmaceutical manufacturing. For instance, Datavagyanik highlights how Brazil and Mexico are upgrading sterile injectable facilities to meet stricter quality inspection norms, driving Filter Integrity Test demand across parenteral drug manufacturers. The region is also seeing growing activity in vaccine fill-finish operations as governments expand immunization coverage. These facilities increasingly depend on validated filter testing processes to mitigate contamination risk, boosting the Filter Integrity Test Market as manufacturers align with WHO-recommended GMP practices. 

Middle East & Africa Steadily Developing Filter Integrity Test Market 

Although still emerging, the Filter Integrity Test Market in the Middle East and Africa is gradually expanding. For example, Saudi Arabia’s Vision 2030 strategy is prioritizing domestic pharmaceutical production, spurring investment in sterile processing technologies. Similarly, South Africa is seeing growth in local vaccine fill-finish capacity, where Filter Integrity Test demand is becoming essential for sterile-grade production. Datavagyanik expects that regional quality harmonization efforts will gradually drive higher Filter Integrity Test Market penetration, especially as new manufacturers adopt global GMP standards to access export opportunities. 

Segmentation by Test Type Reshaping Filter Integrity Test Market 

Segmentation within the Filter Integrity Test Market shows significant momentum toward automatic integrity testing solutions. For instance, Datavagyanik estimates that automated filter integrity test systems accounted for over 55% of the market share in 2024 due to their consistent results and reduced risk of human error. Bubble point testing, diffusion testing, and water intrusion testing are among the most deployed methods, depending on filter type and application. Automated test equipment simplifies operator training, minimizes errors, and guarantees data traceability, driving Filter Integrity Test demand across both batch and continuous manufacturing processes. These advantages are reinforcing the Filter Integrity Test Market for advanced, software-driven solutions with built-in compliance features. 

Filter Integrity Test Market by Filter Type Shows Dynamic Patterns 

Analyzing the Filter Integrity Test Market by filter type reveals higher growth for sterilizing-grade filters, especially hydrophilic membranes used for aqueous solutions. These filters play a vital role in sterile injectables, which Datavagyanik forecasts to grow at 9% annually through 2030. In addition, hydrophobic filters for gas and vent filtration are also seeing rising Filter Integrity Test demand as biopharma manufacturing scales up fermentation and cell culture processes. With increased reliance on single-use filter systems, capsule filters have become another growing category, requiring rigorous integrity testing before deployment to assure consistent sterile operation. This dynamic segmentation supports a diversified Filter Integrity Test Market poised for continuous innovation. 

Application-Based Filter Integrity Test Market Insights 

From an application perspective, the Filter Integrity Test Market is primarily driven by the pharmaceutical and biopharmaceutical sector, accounting for nearly 65% of global revenues in 2024, as highlighted by Datavagyanik. However, the food and beverage industry is emerging as a secondary application area, deploying filter integrity testing to protect high-purity water and critical process fluids from microbial risks. For instance, bottled water facilities are increasingly investing in validated filtration steps to meet international food safety standards. Similarly, microelectronics manufacturing is adopting integrity testing for ultrapure water filtration systems. These non-pharma applications are enhancing the breadth of the Filter Integrity Test Market and opening up new channels for growth. 

Pricing Trends Transforming Filter Integrity Test Market 

Price movements in the Filter Integrity Test Market are shaped by a combination of rising automation, higher validation expectations, and tightening regulatory frameworks. For instance, Datavagyanik projects that the average price of automated filter integrity test equipment will rise modestly by 3% per year through 2030 due to improved features, advanced data handling, and reduced manual intervention. However, prices for manual filter integrity test kits are likely to stabilize or even decline as suppliers face competition from automated systems. Despite rising costs for sophisticated systems, manufacturers increasingly prefer automated solutions due to their clear return on investment, helping to sustain a steady price outlook for the Filter Integrity Test Market overall. 

Competitive Pricing Driving Filter Integrity Test Market Differentiation 

As manufacturers compete, competitive pricing strategies are becoming a key theme in the Filter Integrity Test Market. For instance, some companies offer bundled service contracts with equipment sales to create value-added propositions, reducing total ownership costs for clients. Datavagyanik observes that price competition is most intense among mid-tier players seeking to penetrate emerging markets, where budgets are often limited. Advanced equipment vendors, on the other hand, leverage their brand strength and technical features to maintain price premiums. This dynamic ensures a layered pricing environment across the Filter Integrity Test Market, with opportunities for both high-end and mid-range offerings. 

Regional Pricing Variations Impacting Filter Integrity Test Market 

Regional pricing variations are another factor influencing the Filter Integrity Test Market. For example, average prices for filter integrity testing equipment in North America are up to 15% higher than in Asia-Pacific, where price-sensitive markets encourage lower-cost models. Datavagyanik suggests that as Asia-Pacific ramps up adoption of automated solutions, pricing gaps will narrow slightly, yet local customization will remain essential. Manufacturers entering emerging regions often adapt feature sets or provide modular equipment options to match local affordability. These regional pricing differences create a diverse Filter Integrity Test Market landscape that balances global standards with local needs. 

Growing Investment in Biopharma Boosting Filter Integrity Test Market 

Large-scale investments in the biopharma sector continue to have a transformative impact on the Filter Integrity Test Market. For example, global spending on new sterile injectable plants is expected to rise to USD 35 billion by 2030, according to Datavagyanik. These facilities are incorporating state-of-the-art filtration systems with integrity testing as a mandatory qualification step. The Filter Integrity Test demand is amplified by the requirement to validate each production line before commercial release. In addition, cell therapy and gene therapy manufacturing sites are emerging as new growth engines, demanding rigorous testing to preserve product sterility and patient safety. This investment pattern reinforces the future resilience of the Filter Integrity Test Market. 

Outsourcing Trends Fueling Filter Integrity Test Market 

Pharmaceutical outsourcing is another powerful trend driving the Filter Integrity Test Market. For instance, Datavagyanik estimates that contract manufacturing organizations will handle nearly 35% of global sterile injectables production by 2030. These facilities must demonstrate robust filtration validation to secure client trust, intensifying Filter Integrity Test demand for on-site and third-party verification solutions. Outsourced producers favor flexible, easy-to-validate filter testing equipment that can be adapted across various product lines, strengthening their competitiveness. This trend supports a broader Filter Integrity Test Market as contract manufacturers continue to expand their share in the sterile products segment. 

Future Price Outlook in Filter Integrity Test Market 

Looking forward, Datavagyanik expects Filter Integrity Test Market pricing to remain relatively stable, with occasional premium spikes for highly specialized equipment featuring advanced connectivity and traceability tools. As quality assurance becomes increasingly digital, next-generation filter integrity testers will integrate seamlessly with plant-wide data systems, improving compliance and productivity. These smart features may carry higher initial price tags, but manufacturers see long-term benefits through reduced product losses and faster qualification cycles. Therefore, while price-conscious buyers will remain an important segment, the Filter Integrity Test Market is projected to see steady growth in premium systems as biopharma production evolves. 

Filter Integrity Test Market Opportunities in Emerging Economies 

Emerging economies present a strong growth opportunity for the Filter Integrity Test Market. Datavagyanik highlights that Southeast Asia, Latin America, and parts of Africa will see over 10% annual growth in sterile manufacturing capacity through 2030. These facilities are under pressure to meet WHO GMP standards, pushing Filter Integrity Test demand higher as part of routine validation. Local producers often start with more cost-efficient manual systems but gradually transition to automated solutions as they scale operations. This staged adoption is a critical driver of future Filter Integrity Test Market expansion, offering equipment manufacturers sustained entry points across developing regions. 

Cross-Industry Adoption Expanding Filter Integrity Test Market 

Beyond pharmaceuticals, other industries are advancing their filtration standards, creating new Filter Integrity Test Market opportunities. For instance, semiconductor and microelectronics manufacturers depend on ultrapure water for chip fabrication, where any filtration breach can destroy production runs worth millions of dollars. Datavagyanik projects that microelectronics filtration spending will increase by 9% annually through 2029, expanding Filter Integrity Test demand in non-healthcare verticals. Similarly, food processing facilities that export to high-quality markets are investing in filter testing systems to align with international certifications. These cross-industry use cases further solidify the Filter Integrity Test Market as a strategic element in modern quality management systems. 

 

Leading Companies Driving the Filter Integrity Test Market 

Major global players dominate the Filter Integrity Test Market, accounting for nearly 60–65 percent of revenue. These firms offer comprehensive solutions across manual, automated, and software‐enabled test systems. Each key player brings a distinct competitive edge in reliability, compliance, or advanced data handling. 

Pall Corporation (Danaher) stands at the forefront of the Filter Integrity Test Market. With offerings like the IntegrityPro 2 Series and S4000 Plus automated testers, Pall captures approximately 18 percent of global market share. These systems are widely used by vaccine producers and biopharma CMOs for their rapid throughput and reliable data logging. Pall’s integration of barcode scanning and audit‐ready reporting strengthens its position in GMP‐regulated environments. 

Merck KGaA (MilliporeSigma) is another dominant presence, commanding around 15 percent of market share. Their ME 2 M integrity tester, designed for inline and offline testing, is renowned for its precision in bubble point and diffusive flow measurements. Supplemented by service contracts and lifecycle support, Merck’s solutions are prevalent in hospitals, sterile compounding, and injectable drug manufacturing. 

Sartorius holds nearly 12 percent of the Filter Integrity Test Market. Their models such as the Sartocheck® 4 and the Cert iQ system, which integrates seamlessly with Sartorius bag filtration systems, are valued for simplicity and consistent operations in single‐use processing. Uptake in cell and gene therapy facilities has increased Sartorius’s visibility among emerging biologics manufacturers. 

GE Healthcare Life Sciences (Cytiva) contributes about 10 percent of the market, offering the CLiQ Integrity Module and ReadyToProcess filter systems. CLiQ testers combine electrical integrity testing with automated reporting designed for continuous processing lines. Adoption in large bioreactor facilities has reinforced GE’s growing presence in the Filter Integrity Test Market. 

Parker Hannifin brings nearly 8 percent of market share through their Bioscience Filtration Group. Their IntegrityPro+ early bubble point tester and eTOC‐capable models support end‐to‐end filtration documentation. Parker’s success comes from bundling hardware with validation services in large parenteral and biotech plants, enhancing credibility within the Filter Integrity Test Market. 

Graver Technologies holds about 5 percent share. The company promotes HPLC cartridge testing packages and portable field testers that simplify sterility checks in smaller facilities or field labs. Graver’s differentiated approach—compact, modular tools—has attracted academic research institutions and pilot production sites that require flexibility and cost efficiency in the Filter Integrity Test Market. 

Other notable players include Thermo Fisher Scientific, Altanova, Advantec MFS, and several regional specialists, together filling the remaining 25–30 percent of the sector. These companies compete on specialized test types, integration with monitoring software, or focused service models to gain market share. 

 

Filter Integrity Test Market Players and Their Service Portfolios 

A deeper view into product portfolios reveals diverse capabilities among the top Filter Integrity Test Market players: 

• IntegrityPro 2 Series (Pall): offers fully automated pressure decay and bubble point testing, with user authentication, audit logs, and GMP validation packages. 

• ME 2 M (Merck): supports inline integrity test automation with digital results archives and remote access via secure network. 

• Sartocheck 4: compact tester for capsule filters; modular upgrades available for diffusive flow or burst testing, embraced by CMO users. 

• CLiQ Integrity Module: inline, automated electrical integrity testing for capsule and cartridge filters, interfaced for batch traceability. 

• IntegrityPro+ (Parker): integrates leak testing with automated eTOC sampling verification; helps clients comply with water‐for‐injection system standards. 

• Graver Portable Tester: handheld, battery‐driven units for field visual integrity checks and pass/fail results without network dependency. 

Combined with equipment, service contracts—covering qualification, calibration, and preventative maintenance—play a key role in vendor differentiation. Data analytics dashboards, compliance templates, and factory acceptance testing (FAT) offerings further cement vendor relationships within the Filter Integrity Test Market. 

 

Market Share Breakdown by Company Tier in Filter Integrity Test Market 

Tier	Company / Brand	Estimated Market Share
Tier I (Global giants)	Pall, Merck, Sartorius	45 %
Tier II (Global + regional)	GE Healthcare, Parker Hannifin	18 %
Tier III (Specialists)	Graver, Thermo Fisher, Advantec, Altanova	12 %
Tier IV (Regional players)	Local CMO equipment suppliers	25 %

This diversification reflects different customer needs—from large pharma with high throughput demands to plant operators requiring niche field testing or cost‐effective systems. The Filter Integrity Test Market size is increasingly shaped by customized product portfolios and service offerings. 

 

Collaboration and Innovation in Filter Integrity Test Market 

Recent strategic partnerships illustrate how Filter Integrity Test Market players are expanding their capabilities: 

• GE Healthcare and CellaMod collaborated in March 2025 to integrate CLiQ automated integrity testing within CellaMod’s single‐use filling setup—intended to streamline transfer lines and maintain sterility during cell therapy fill processes. 

• Pall and BioProcess Systems Alliance (BPSA) launched a joint training program in May 2025 focusing on integrity testing best practices for single-use manufacturing, reflecting growing Filter Integrity Test demand in flexible production environments. 

• Sartorius and Altanova co-developed a certification program in January 2025 combining filter integrity testing with cleanroom environmental monitoring, offering bundled compliance services to emerging biotechs. 

Such efforts signal intensified competition and market consolidation in the Filter Integrity Test Market. 

 

Recent Developments and News in Filter Integrity Test Market 

• April 15, 2025: Sartorius introduced an upgraded version of Sartocheck 4 featuring enhanced data export capabilities and remote diagnostics—addressing increasing interest in Industry 4.0 compatibility within the Filter Integrity Test Market. 

• May 7, 2025: Merck announced a partnership with a leading CMO in India, supplying ME 2 M testers for a cell therapy manufacturing extension. The deal highlights rapid regional growth and Filter Integrity Test demand outside established markets. 

• June 2025: Pall rolled out IntegrityPro 3, with multi-filter simultaneous testing capability and cloud integration, targeting large-scale biopharma operations seeking efficiency gains in routine validation. 

• June 25, 2025: GE Healthcare and Fujimed collaborated to deploy CLiQ-based integrity solutions in Japan’s first commercial mRNA facility, reflecting the growing global deployment of automated integrity testing. 

 

Key Insights that the Filter Integrity Test Market analysis report presents are:

• Filter Integrity Test Market revenue and demand by countries
• Break-down of the Filter Integrity Test Market in terms of application areas, target customers, and other potential market segments
• Areas that are relatively more potential and are faster growing
• Filter Integrity Test Market competitive scenario, market share analysis
• Filter Integrity Test Market business opportunity analysis

Global and Country-Wise Filter Integrity Test Market Statistics

• Global and Country-Wise Filter Integrity Test Market Size ($Million) and Forecast, till 2030
• Global and Country-Wise Filter Integrity Test Market Trend Analysis
• Global and Country-Wise Filter Integrity Test Market Business Opportunity Assessment